NetworkNewsBreaks

WednesdayAug 12, 2020 10:09 am

NetworkNewsBreaks – Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA) Featured in Mizuho Securities Research Report

Satsuma Pharmaceuticals (NASDAQ: STSA) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “Satsuma reported 2Q20 earnings that were close to Street expectations with a net loss of ($11.3M) (vs. Mizuho at ($12.7M) and consensus at ($12.8M)), and EPS of ($0.65) (vs. Mizuho at ($0.69) and consensus at ($0.73)). More importantly for a clinical-stage company such as Satsuma is the progress they are making with their pipeline, and all parts of the STS101 program appear on track. The company recently announced completion of the treatment phase of the Phase 3 EMERGE trial…

Continue Reading

TuesdayAug 11, 2020 2:51 pm

NetworkNewsBreaks – The Very Good Food Company Inc. (CSE: VERY) (FSE: 0SI) Achieves Next Critical Step in Scaling Ecommerce Business

The Very Good Food Company (CSE: VERY) (FSE: 0SI) today announced its entry into an agreement with three third party logistics providers ("3PL") to increase shipping speed and reduce associated costs for its ecommerce store orders. The company also completed improvements to its Victoria facility to increase throughput and position it for a near-term ramp up in production. "The 3PL hubs were the next critical step in building our ecommerce business to be truly scalable,” The Very Good Food Company CEO, Mitchell Scott, stated in the news release. “Previously, all shipping was centralized out of our Victoria facility, which delayed…

Continue Reading

TuesdayAug 11, 2020 1:19 pm

NetworkNewsBreaks – Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) Featured in Mizuho Securities Research Report

Biohaven Pharmaceutical Holding Company (NYSE: BHVN) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “We are updating our Biohaven model after 2Q20 earnings, accounting for the results and the recently announced financing agreement with Royalty Pharma (RPRX; Not Covered) and term loan with Sixth Street to support Nurtec ODT's ongoing launch and the development of zavegepant. We believe these agreements provide attractive forms of financing that obviate the near-term need for additional capital raise, while allowing Biohaven to compete in the migraine market. Nurtec's uptake continues to impress us, and we…

Continue Reading

TuesdayAug 11, 2020 1:11 pm

NetworkNewsBreaks – Revance Therapeutics, Inc. (NASDAQ: RVNC) Featured in Mizuho Securities Research Report

Revance Therapeutics (NASDAQ: RVNC) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “We are assuming coverage of Revance Therapeutics with a Buy rating and $32 PT (from $35). We see the aesthetics market as an attractive one over the long term, despite the significant challenges and uncertainty it is facing given the ongoing COVID-19 pandemic. We forecast a slow launch for both Daxi and Revance’s RHA Collection dermal filler line, but expect enough positive progress, along with positive data from therapeutic indications, for continued stock appreciation. Our estimates are guided by…

Continue Reading

TuesdayAug 11, 2020 12:55 pm

NetworkNewsBreaks – AVAIL Vapor Announces PMTA Acceptance from FDA for e-Liquid Nicotine Offerings

AVAIL Vapor, a leading premium U.S. retailer, has received its first Premarket Tobacco Application (“PMTA”) acceptance from the U.S. Food and Drug Administration (“FDA”). The PMTA was received for AVAIL’s e-liquid nicotine product line. The company is in the process of filing several similar applications before the Sept. 9, 2020, PMTA deadline in line with its strategy to offer a variety of products to adults seeking alternative choices to combustible tobacco products. The e-liquid nicotine product application will now enter the substantive scientific review stage, during which the FDA will identify whether AVAIL has proven that its nicotine vaping products…

Continue Reading

TuesdayAug 11, 2020 12:36 pm

NetworkNewsBreaks – Net Element, Inc.’s (NASDAQ: NETE) Pending Merger Partner to Present at J.P. Morgan Virtual Auto Conference

Mullen Technologies ("Mullen" or the "Company"), an emerging electric vehicle ("EV") manufacturer and technology company, which previously announced a definitive agreement to merge with Net Element (NASDAQ: NETE) in a stock-for-stock reverse merger, today announced that the Company will present at the J.P. Morgan Virtual Auto Conference. During the presentation, scheduled to take place at 9:20 a.m. Eastern Time on Wednesday, August 12, Mullen’s CEO, David Michery, will outline the Company's path to electric vehicle production in 2022 and its proprietary technology platform. Interested parties may access the Company’s presentation live at J.P Morgan/MullenTech. A question and answer session for…

Continue Reading

TuesdayAug 11, 2020 12:04 pm

NetworkNewsBreaks – Appreciated Media Holdings Inc. (TSX.V: AMH) (OTCQB: AMEFF) Director Resigns

Vancouver-based Appreciated Media Holdings (TSX.V: AMH) (OTCQB: AMEFF), a multifaceted entertainment company, has announced that its director of the corporation, Sean Kingsley, has resigned. Kingsley’s resignation is effective Aug. 10, 2020. In the press release, the company thanked Kingsley for his contributions to Appreciated Media Holdings and noted that efforts are now underway to replace the departing executive. To view the full press release, visit http://nnw.fm/T4gHI About Appreciated Media Holdings Inc. Appreciated Media is a multi-faceted entertainment company based in Vancouver. The Company has a new CEO at the helm and has divisions in the film, music and television industries.…

Continue Reading

TuesdayAug 11, 2020 11:46 am

NetworkNewsBreaks – InvestorBrandNetwork Announces Launch of Laser-Focused Communications Platform – MiningNewsWire

InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment community, today announced the launch of MiningNewsWire (“MNW”) as part of its sustained effort to provide specialized content distribution via widespread syndication channels. A specialized, laser-focused communications platform, MNW publishes news, content and information on mining stocks and natural resource companies operating around the globe. “Mining stocks are unique in that they move independently based on situational demand. As a result, mining stocks can produce strong returns during any market cycle. This is particularly apparent today. As the 2020 pandemic continues to foment economic uncertainty, demand…

Continue Reading

TuesdayAug 11, 2020 11:22 am

NetworkNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Launches First-of-Its-Kind B2B Platform

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform,has unveiled Bonum+, a business-to-business platform that bundles telehealth, a COVID-19 risk assessment tool and a Personal Protective Equipment (“PPE”) purchasing tool together. Available through MEDS subsidiary Bonum Health, the platform, which is the first of its kind, will be available through a secure mobile dashboard and is designed to ease pressure on employees who are mandated to report relevant health issues daily. Bonum+ centralizes communication and contact tracing to deliver risk scores. “I am proud of the entire team at Bonum Health, a Trxade Group company, for their efforts…

Continue Reading

TuesdayAug 11, 2020 11:01 am

NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Shareholder Letter Highlights Achievements, Discusses Two Key Proposals

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, outlined the company’s recent accomplishments in a letter released to shareholders. The letter, sent from CEO Dr. Carl Schwartz, also summarized voting recommendations from POAI’s Board of Directors regarding two proposals that are scheduled for shareholder vote next month. “Predictive Oncology is committed to executing our strategic vision to develop and commercialize an offering that will enable us to support the improvement in healthcare outcomes for oncology patients and increase value for our shareholders,” stated Schwartz in a press release containing…

Continue Reading